Berberine inhibits the proliferation of prostate cancer cells and induces G0/G1 or G2/M phase arrest at different concentrations

Lu,Wei; Du,Shanshan; Wang,Jiaqiang

doi:10.3892/mmr.2014.3139

Berberine inhibits the proliferation of prostate cancer cells and induces G0/G1 or G2/M phase arrest at different concentrations

Authors:
- Wei Lu
- Shanshan Du
- Jiaqiang Wang
View Affiliations

Affiliations: Department of Urology, Jilin Province People's Hospital, Changchun, Jilin 130021, P.R. China
Published online on: December 30, 2014 https://doi.org/10.3892/mmr.2014.3139
Pages: 3920-3924

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Prostate cancer is the second most common disease of the male reproductive system. Berberine is a quaternary ammonium salt that is extracted from plants. The aim of the current study was to explore the antitumor activity of berberine in prostate cancer cells and identify the underlying mechanism of its effects. PC3 human and RM‑1 mouse prostate cancer cells were treated with increasing concentrations of berberine, followed by analysis of the cell viability with an MTT assay. The results demonstrated that berberine markedly inhibited the proliferation of PC3 and RM‑1 cells, and that the inhibitory effects to PC3 and RM‑1 were enhanced in a concentration‑ and time‑dependent manner. Flow cytometry was used to analyze the cell cycle of PC3 human prostate cancer cells, and the results demonstrated that G0/G1 phase arrest was induced following treatment with 10 µM berberine (P<0.05). However, with an increased concentration of berberine (50 µM) the survival rate of PC3 cells at the G2/M phase was significantly increased compared with the cells treated with 10 µM berberine, which suggests that different cell cycle signaling pathways were activated when PC3 cells were treated with low and high concentrations of berberine. Thus, clarifying the mechanism underlying these effects in prostate cancer may provide novel molecular targets for prostate cancer therapy.

View Figures

View References

1	Xiao H, Tan F, Goovaerts P, et al: Multilevel factors associated with overall mortality for men diagnosed with prostate cancer in florida. Am J Mens Health. 8:316–326. 2013. View Article : Google Scholar : PubMed/NCBI
2	Gerritse FL, Meulenbeld HJ, Roodhart JM, et al: Analysis of docetaxel therapy in elderly (≥70 years) castration resistant prostate cancer patients enrolled in the Netherlands Prostate Study. Eur J Cancer. 49:3176–3183. 2013. View Article : Google Scholar : PubMed/NCBI
3	Damaschke NA, Yang B, Bhusari S, Svaren JP and Jarrard DF: Epigenetic susceptibility factors for prostate cancer with aging. Prostate. 73:1721–1730. 2013. View Article : Google Scholar : PubMed/NCBI
4	No authors listed. Summaries for patients. Effect of age, tumor risk, and comorbidity on prostate cancer survival. Ann Intern Med. 158:709–717. 2013. View Article : Google Scholar
5	Greenberg DC, Wright KA, Lophathanon A, Muir KR and Gnanapragasam VJ: Changing presentation of prostate cancer in a UK population - 10 year trends in prostate cancer risk profiles in the East of England. Br J Cancer. 109:2115–2120. 2013. View Article : Google Scholar : PubMed/NCBI
6	Carter HB: American Urological Association (AUA) guideline on prostate cancer detection: process and rationale. BJU Int. 112:543–547. 2013. View Article : Google Scholar : PubMed/NCBI
7	Lamy S, Wilmart JF, Hein T, Scheiden R and Capesius C: Prostate cancer in Luxembourg from 1982 to 2006. Incidence and mortality. Survival of a hospital cohort. Bull Soc Sci Med Grand Duche Luxemb. 6–19. 2013.(In French).
8	Peng P, Gong YM, Bao PP, et al: Estimates and prediction of prostate cancer incidence, mortality and prevalence in China, 2008. Zhonghua Liu Xing Bing Xue Za Zhi. 33:1056–1059. 2012.(In Chinese).
9	Zhang L, Wu S, Guo LR and Zhao XJ: Diagnostic strategies and the incidence of prostate cancer: reasons for the low reported incidence of prostate cancer in China. Asian J Androl. 11:9–13. 2009. View Article : Google Scholar
10	Song FJ, Zhang BL, He M, et al: Trend analysis of the incidence of prostate cancer in Tianjin between 1981 and 2004. Zhonghua Yi Xue Za Zhi. 90:2811–2814. 2010.(In Chinese). PubMed/NCBI
11	Wang JR, Tanaka T, Zhang H, Kouno I and Jiang ZH: Formation and conformation of baicalin-berberine and wogonoside-berberine complexes. Chem Pharm Bull (Tokyo). 60:706–711. 2012. View Article : Google Scholar
12	Philogène BJ, Arnason JT, Towers GH, et al: Berberine: A naturally occurring phototoxic alkaloid. J Chem Ecol. 10:115–123. 1984. View Article : Google Scholar : PubMed/NCBI
13	Li B, Zhu WL and Chen KX: Advances in the study of berberine and its derivatives. Yao Xue Xue Bao. 43:773–787. 2008.(In Chinese). PubMed/NCBI
14	Chin LW, Cheng YW, Lin SS, et al: Anti-herpes simplex virus effects of berberine from Coptidis rhizoma, a major component of a Chinese herbal medicine, Ching-Wei-San. Arch Virol. 155:1933–1941. 2010. View Article : Google Scholar : PubMed/NCBI
15	Derosa G and Maffioli P: Alkaloids in the nature: pharmacological applications in clinical practice of berberine and mate tea. Curr Top Med Chem. 14:200–206. 2014. View Article : Google Scholar
16	Zhang Q, Piao XL, Piao XS, Lu T, Wang D and Kim SW: Preventive effect of Coptis chinensis and berberine on intestinal injury in rats challenged with lipopolysaccharides. Food Chem Toxicol. 49:61–69. 2011. View Article : Google Scholar
17	Yao J, Kong W and Jiang J: Learning from berberine: Treating chronic diseases through multiple targets. Sci China Life Sci. Oct 30–2013.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
18	Doggrell SA: Berberine - a novel approach to cholesterol lowering. Expert Opin Investig Drugs. 14:683–685. 2005. View Article : Google Scholar : PubMed/NCBI
19	Affuso F, Mercurio V, Fazio V and Fazio S: Cardiovascular and metabolic effects of Berberine. World J Cardiol. 2:71–77. 2010. View Article : Google Scholar : PubMed/NCBI
20	Chappell WH, Abrams SL, Franklin RA, et al: Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine. Cell Cycle. 11:4447–4461. 2012. View Article : Google Scholar : PubMed/NCBI
21	Yu M, Tong X, Qi B, et al: Berberine enhances chemosensitivity to irinotecan in colon cancer via inhibition of NFκB. Mol Med Rep. 9:249–254. 2014.
22	Pierpaoli E, Arcamone AG, Buzzetti F, Lombardi P, Salvatore C and Provinciali M: Antitumor effect of novel berberine derivatives in breast cancer cells. Biofactors. 39:672–679. 2013. View Article : Google Scholar : PubMed/NCBI
23	Hur JM and Kim D: Berberine inhibited radioresistant effects and enhanced anti-tumor effects in the irradiated-human prostate cancer cells. Toxicol Res. 26:109–115. 2010. View Article : Google Scholar : PubMed/NCBI
24	Bernas T and Dobrucki J: Mitochondrial and nonmitochondrial reduction of MTT: interaction of MTT with TMRE, JC-1, and NAO mitochondrial fluorescent probes. Cytometry. 47:236–242. 2002. View Article : Google Scholar : PubMed/NCBI
25	Sylvester PW: Optimization of the tetrazolium dye (MTT) colorimetric assay for cellular growth and viability. Methods Mol Biol. 716:157–168. 2011. View Article : Google Scholar : PubMed/NCBI
26	Zhou ZR, Zhu XD, Xia J, et al: Short-term versus long-term hormone therapy plus radiotherapy or prostatectomy for prostate cancer: a systematic review and meta-analysis. J Cancer Res Clin Oncol. 139:783–796. 2013. View Article : Google Scholar : PubMed/NCBI
27	Huang ZJ, Zeng Y, Lan P, Sun PH and Chen WM: Advances in structural modifications and biological activities of berberine: an active compound in traditional Chinese medicine. Mini Rev Med Chem. 11:1122–1129. 2011. View Article : Google Scholar
28	Pierpaoli E, Arcamone AG, Buzzetti F, Lombardi P, Salvatore C and Provinciali M: Antitumor effect of novel berberine derivatives in breast cancer cells. Biofactors. 39:672–679. 2013. View Article : Google Scholar : PubMed/NCBI
29	Goto H, Kariya R, Shimamoto M, et al: Antitumor effect of berberine against primary effusion lymphoma via inhibition of NF-κB pathway. Cancer Sci. 103:775–781. 2012. View Article : Google Scholar : PubMed/NCBI
30	Wang Z, Chen Z, Yang S, et al: Berberine ameliorates collagen-induced arthritis in rats associated with anti-inflammatory and anti-angiogenic effects. Inflammation. 37:1789–1798. 2014. View Article : Google Scholar : PubMed/NCBI
31	Barzilai A and Yamamoto K: DNA damage responses to oxidative stress. DNA Repair (Amst). 3:1109–1115. 2004. View Article : Google Scholar
32	Muralimanoharan SB, Kunnumakkara AB, Shylesh B, et al: Butanol fraction containing berberine or related compound from nexrutine inhibits NFkappaB signaling and induces apoptosis in prostate cancer cells. Prostate. 69:494–504. 2009. View Article : Google Scholar :
33	Choi MS, Oh JH, Kim SM, et al: Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells. Int J Oncol. 34:1221–1230. 2009.PubMed/NCBI
34	Kim JB, Lee KM, Ko E, et al: Berberine inhibits growth of the breast cancer cell lines MCF-7 and MDA-MB-231. Planta Med. 74:39–42. 2008. View Article : Google Scholar : PubMed/NCBI
35	Chidambara Murthy KN, Jayaprakasha GK and Patil BS: The natural alkaloid berberine targets multiple pathways to induce cell death in cultured human colon cancer cells. Eur J Pharmacol. 688:14–21. 2012. View Article : Google Scholar : PubMed/NCBI
36	Yan L, Yan K, Kun W, et al: Berberine inhibits the migration and invasion of T24 bladder cancer cells via reducing the expression of heparanase. Tumor Biol. 34:215–221. 2013. View Article : Google Scholar
37	Letasiova S, Jantova S, Cipak L and Muckova M: Berberine-antiproliferative activity in vitro and induction of apoptosis/necrosis of the U937 and B16 cells. Cancer Lett. 239:254–262. 2006. View Article : Google Scholar
38	Liu Z, Liu Q, Xu B, et al: Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage. Mutat Res. 662:75–83. 2009. View Article : Google Scholar : PubMed/NCBI